Filing Flows › Versigent (VGNT) › Capital expenditures
Versigent (VGNT) capital expenditures by quarter
Versigent's capital expenditures were $55.0M in Q3 2026 (third quarter 2026), +8% from Q2 2026. Over the last 3 quarters it ranged from $51.0M (Q2 2026) to $66.0M (Q1 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $55.0M | +8% | — |
| Q2 2026 | $51.0M | -23% | — |
| Q1 2026 | $66.0M | — | — |
Q3 2026 at a glance
Versigent, Q3 2026: revenue $2.5B (+7% year over year), operating margin 7.6%, net earnings $102M, operating cash flow $225M. The chart follows the revenue to costs, profit and cash.
Questions
What is Versigent's capital expenditures?
Versigent's capital expenditures were $55.0M in Q3 2026 (third quarter 2026), +8% from Q2 2026.
How has Versigent's capital expenditures changed?
Over the last 3 quarters it ranged from $51.0M (Q2 2026) to $66.0M (Q1 2026).